Clinical trial
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine
NCT06471348 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine
- Lead sponsor
- Boston Children's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 15, 2025
- Completion date
- August 31, 2028
- Enrollment
- 128 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post operative pain, spinal fusion